BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33219687)

  • 1. Prophages are associated with extensive CRISPR-Cas auto-immunity.
    Nobrega FL; Walinga H; Dutilh BE; Brouns SJJ
    Nucleic Acids Res; 2020 Dec; 48(21):12074-12084. PubMed ID: 33219687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen.
    Hargreaves KR; Flores CO; Lawley TD; Clokie MR
    mBio; 2014 Aug; 5(5):e01045-13. PubMed ID: 25161187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
    Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
    Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
    PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of Single Prophage Carrying a CRISPR/cas System in "Candidatus Liberibacter asiaticus" Strains in Southern China.
    Zheng Z; Bao M; Wu F; Chen J; Deng X
    PLoS One; 2016; 11(1):e0146422. PubMed ID: 26741827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of CRISPR-Cas systems in Klebsiella genomes.
    Shen J; Lv L; Wang X; Xiu Z; Chen G
    J Basic Microbiol; 2017 Apr; 57(4):325-336. PubMed ID: 28156004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
    Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
    Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response.
    Heler R; Wright AV; Vucelja M; Bikard D; Doudna JA; Marraffini LA
    Mol Cell; 2017 Jan; 65(1):168-175. PubMed ID: 28017588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers.
    Pourcel C; Touchon M; Villeriot N; Vernadet JP; Couvin D; Toffano-Nioche C; Vergnaud G
    Nucleic Acids Res; 2020 Jan; 48(D1):D535-D544. PubMed ID: 31624845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas Systems Optimize Their Immune Response by Specifying the Site of Spacer Integration.
    McGinn J; Marraffini LA
    Mol Cell; 2016 Nov; 64(3):616-623. PubMed ID: 27618488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The driving force of prophages and CRISPR-Cas system in the evolution of Cronobacter sakazakii.
    Zeng H; Zhang J; Li C; Xie T; Ling N; Wu Q; Ye Y
    Sci Rep; 2017 Jan; 7():40206. PubMed ID: 28057934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.
    Maikova A; Boudry P; Shiriaeva A; Vasileva A; Boutserin A; Medvedeva S; Semenova E; Severinov K; Soutourina O
    mBio; 2021 Aug; 12(4):e0213621. PubMed ID: 34425703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
    Goldberg GW; Jiang W; Bikard D; Marraffini LA
    Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
    He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer.
    Richter C; Dy RL; McKenzie RE; Watson BN; Taylor C; Chang JT; McNeil MB; Staals RH; Fineran PC
    Nucleic Acids Res; 2014 Jul; 42(13):8516-26. PubMed ID: 24990370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.